The company did, however, point out that the FDA has taken 16.5 months to review an application with a priority review and has now been considering the drug for more than five years.

What non-SSRI antidepressants or non-SSRI anxiety meds are out there? We’ll talk not only about alternatives to SSRIs but the ...